Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kaufmann

Showing results (651-660 of 720) with videos related to

Pageof 72
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapyP Reichardt, G Von Minckwitz, P C Thuss-Patience, et al.
Journal of Gynecologic Oncology|March 20, 2019
A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patientsTheresa Maria Kolben, Lea T Etzel, Florian Bergauer, et al.
Leukemia|December 8, 2010
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialF Stölzel, M Pfirrmann, W E Aulitzky, et al.
BMC Palliative Care|August 5, 2020
Factors influencing GPs' perception of specialised palliative homecare (SPHC) importance - results of a cross-sectional studyK Stichling, M Krause, B Ditscheid, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 3, 2009
A comparison of the ability of the EEGo and BIS monitors to assess emergence following neurosurgeryRyan J Pauls, Timothy J Dickson, Anthony M Kaufmann, et al.
The Clinical Neuropsychologist|February 28, 2024
Attorney demands for protected psychological test information: Is access necessary for cross examination or does it lead to misinformation? An interorganizational* position paperKyle Brauer Boone, Paul M Kaufmann, Jerry J Sweet, et al.
Cancer|March 8, 2016
A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancersMiriam Reuschenbach, Claudia Pauligk, Julia Karbach, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 7, 2006
Uterotubal transport disorder in adenomyosis and endometriosis--a cause for infertilityS Kissler, N Hamscho, S Zangos, et al.
American Journal of Respiratory and Critical Care Medicine|December 31, 1997
Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDSC R Carvalho, C S Barbas, D M Medeiros, et al.
Anti-Cancer Drugs|August 13, 2005
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBCG von Minckwitz, I Chernozemsky, L Sirakova, et al.
Pageof 72

Showing results (651-660 of 720) with videos related to

Sort By:
Pageof 72
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapyP Reichardt, G Von Minckwitz, P C Thuss-Patience, et al.
Journal of Gynecologic Oncology|March 20, 2019
A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patientsTheresa Maria Kolben, Lea T Etzel, Florian Bergauer, et al.
Leukemia|December 8, 2010
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialF Stölzel, M Pfirrmann, W E Aulitzky, et al.
BMC Palliative Care|August 5, 2020
Factors influencing GPs' perception of specialised palliative homecare (SPHC) importance - results of a cross-sectional studyK Stichling, M Krause, B Ditscheid, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 3, 2009
A comparison of the ability of the EEGo and BIS monitors to assess emergence following neurosurgeryRyan J Pauls, Timothy J Dickson, Anthony M Kaufmann, et al.
The Clinical Neuropsychologist|February 28, 2024
Attorney demands for protected psychological test information: Is access necessary for cross examination or does it lead to misinformation? An interorganizational* position paperKyle Brauer Boone, Paul M Kaufmann, Jerry J Sweet, et al.
Cancer|March 8, 2016
A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancersMiriam Reuschenbach, Claudia Pauligk, Julia Karbach, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 7, 2006
Uterotubal transport disorder in adenomyosis and endometriosis--a cause for infertilityS Kissler, N Hamscho, S Zangos, et al.
American Journal of Respiratory and Critical Care Medicine|December 31, 1997
Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDSC R Carvalho, C S Barbas, D M Medeiros, et al.
Anti-Cancer Drugs|August 13, 2005
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBCG von Minckwitz, I Chernozemsky, L Sirakova, et al.
Pageof 72